| [1] |
Khurshid S, Obeng-Gyimah E, Supple GE, et al. Reversal of pacing-induced cardiomyopathy following cardiac resyn‐chronization therapy[J]. JACC Clin Electrophysiol, 2018,4(2):168-177.
|
| [2] |
Vijayaraman P, Herweg B, Verma A, et al. Rescue left bun‐dle branch area pacing in coronary venous lead failure or nonresponse to biventricular pacing: results from Interna‐tional LBBAP Collaborative Study Group[J]. Heart Rhythm, 2022, 19(8):1272-1280.
|
| [3] |
Chen J, Cheng L, Wang Z, et al. Comparison of efficacy and safety of His-Purkinje system pacing versus cardiac resyn‐chronisation therapy in patients with pacing-induced car‐diomyopathy: protocol for a randomised controlled trial[J]. BMJ Open, 2021, 11(8):e045302.
|
| [4] |
Costa R, Silva K, Crevelari ES, et al. Effectiveness and safe‐ty of transvenous removal of cardiac pacing and implant‐able cardioverter-defibrillator leads in the real clinical scenario[J]. Arq Bras Cardiol, 2020, 115(6):1114-1124.
|
| [5] |
Kaye G, Ng JY, Ahmed S, et al. The prevalence of pacing-in‐duced cardiomyopathy (PICM) in patients with long term right ventricular pacing - is it a matter Of Definition?[J].Heart Lung Circ, 2019, 28(7):1027-1033.
|
| [6] |
Kaza N, Htun V, Miyazawa A, Simader F, et al. Upgrading right ventricular pacemakers to biventricular pacing or conduction system pacing: a systematic review and me‐ta-analysis[J]. Europace, 2023, 25(3):1077-1086.
|
| [7] |
Normand C, Linde C, Singh J, et al. Indications for cardiac resynchronization therapy: a comparison of the major in‐ternational guidelines[J]. JACC Heart Fail, 2018, 6(4):308-316.
|
| [8] |
Schwertner WR, Behon A, Merkel ED, et al. Long-term sur‐vival following upgrade compared with de novo cardiac resynchronization therapy implantation: a single-centre,high-volume experience[J]. Europace, 2021, 23(8):1310-1318.
|
| [9] |
Jędrzejczyk‐Patej E, Mazurek M, Kotalczyk A, et al. Up‐grade from implantable cardioverter-defibrillator vs. de novo implantation of cardiac resynchronization therapy:long-term outcomes[J]. Europace, 2021, 23(1):113-122.
|
| [10] |
Chung MK, Patton KK, Lau CP, et al. 2023 HRS/APHRS/LA‐HRS Guideline on cardiac physiologic pacing for the avoid‐ance and mitigation of heart failure[J]. Heart Rhythm,2023, 20(9):e17-e91.
|
| [11] |
Kosztin A, Vamos M, Aradi D, et al. De novo implantation vs. upgrade cardiac resynchronization therapy: a system‐atic review and meta-analysis[J]. Heart Fail Rev, 2018,23(1):15-26.
|
| [12] |
Daubert C, Behar N, Martins RP, et al. Avoiding non-re‐sponders to cardiac resynchronization therapy: a practi‐cal guide[J]. Eur Heart J, 2017, 38(19):1463-1472.
|
| [13] |
Spragg DD. Left ventricular endocardial pacing for cardiac resynchronization therapy: wavefront of the future?[J].JACC Clin Electrophysiol, 2016, 2(4):423-425.
|
| [14] |
Vinther M, Risum N, Svendsen JH, et al. A randomized trial of His pacing versus biventricular pacing in symptomatic HF patients with left bundle branch block (His-Alterna‐tive)[J]. JACC Clin Electrophysiol, 2021, 7(11):1422-1432.
|
| [15] |
吴功林, 徐伟, 白剑, 等. 希氏-浦肯野系统起搏与双心室起搏治疗房室传导阻滞伴射血分数降低患者的疗效观察[J].中华心律失常学杂志, 2023, 27(3):253-257.
|
| [16] |
Ma C, Wang Z, Ma Z, et al. The feasibility and safety of his-purkinje conduction system pacing in patients with heart failure with severely reduced ejection fraction[J].Front Cardiovasc Med, 2023, 10:1187169.
|
| [17] |
Rademakers LM, Bouwmeester S, Mast TP, et al. Feasibili‐ty, safety and outcomes of upgrading to left bundle branch pacing in patients with right ventricular pacing in‐duced cardiomyopathy[J]. Pacing Clin Electrophysiol,2022, 45(6):726-732.
|
| [18] |
Vijayaraman P, Herweg B, Dandamudi G, et al. Outcomes of His-bundle pacing upgrade after long-term right ven‐tricular pacing and/or pacing-induced cardiomyopathy:Insights into disease progression[J]. Heart Rhythm, 2019,16(10):1554-1561.
|
| [19] |
中华医学会心电生理和起搏分会, 中国医师协会心律学专业委员会. 希氏-浦肯野系统起搏中国专家共识[J]. 中华心律失常学杂志, 2021, 25(1):10-36.
|
| [20] |
Qian Z, Wang Y, Hou X, et al. Efficacy of upgrading to left bundle branch pacing in patients with heart failure after right ventricular pacing[J]. Pacing Clin Electrophysiol,2021, 44(3):472-480.
|
| [21] |
Li H, Wang L, Peng X, et al. The quality of life of patients with pacemaker-induced cardiomyopathy after they up‐grade to left bundle branch pacing[J]. Am J Transl Res,2021, 13(4):3044-3053.
|
| [22] |
Ye Y, Wu S, Su L, et al. Feasibility and outcomes of upgrad‐ing to left bundle branch pacing in patients with pac‐ing-induced cardiomyopathy and infranodal atrioventric‐ular block[J]. Front Cardiovasc Med, 2021, 8:674452.
|
| [23] |
Yang YH, Wang KX, Ma PP, et al. His-purkinje system pac‐ing upgrade improve the heart performances in patients suffering from pacing-induced cardiomyopathy with or without permanent atrial fibrillation[J]. Int J Cardiol,2021, 335:47-51.
|
| [24] |
Vijayaraman P, Herweg B, Dandamudi G, et al. Outcomes of His-bundle pacing upgrade after long-term right ven‐tricular pacing and/or pacing-induced cardiomyopathy:Insights into disease progression[J]. Heart Rhythm, 2019,16(10):1554-1561.
|
| [25] |
Shan P, Su L, Zhou X, et al. Beneficial effects of upgrading to His bundle pacing in chronically paced patients with left ventricular ejection fraction ＜50[J]. Heart Rhythm,2018, 15(3):405-412.
|
| [26] |
Heckman L, Luermans J, Curila K, et al. Comparing Ven‐tricular synchrony in left bundle branch and left ventricu‐lar septal pacing in pacemaker patients[J]. J Clin Med,2021, 10(4):822.
|
| [27] |
Chen X, Qian Z, Zou F, et al. Differentiating left bundle branch pacing and left ventricular septal pacing: an algo‐rithm based on intracardiac electrophysiology[J]. J Cardio‐vasc Electrophysiol, 2022, 33(3):448-457.
|
| [28] |
Parale C, Bootla D, Jain A, et al. Comparison of electrocar‐diographic parameters between left bundle optimized cardiac resynchronization therapy (LOT-CRT) and left bundle branch pacing-cardiac resynchronization therapy(LBBP-CRT)[J]. Pacing Clin Electrophysiol, 2023, 46(8):840-847.
|
| [29] |
Jastrzębski M, Moskal P, Huybrechts W, et al. Left bundle branch-optimized cardiac resynchronization therapy(LOT-CRT): results from an international LBBAP collabor‐ative study group[J]. Heart Rhythm, 2022, 19(1):13-21.
|
| [30] |
Chen X, Li X, Bai Y, et al. Electrical Resynchronization and clinical outcomes during long-term follow-up in intraven‐tricular conduction delay patients applied left bundle branch pacing-optimized cardiac resynchronization thera‐py[J]. Circ Arrhythm Electrophysiol, 2023, 16(9):e011761.
|
| [31] |
Boarescu PM, Roşian AN, Roşian ŞH. Transvenous lead ex‐traction procedure-indications, methods, and complica‐tions[J]. Biomedicines, 2022, 10(11):2780.
|
| [32] |
Swerdlow CD, Kalahasty G, Ellenbogen KA. Implantable cardiac defibrillator lead failure and management[J]. J Am Coll Cardiol, 2016, 67(11):1358-1368.
|
| [33] |
吴翔, 蓝荣芳, 王天琦, 等. 经静脉移除除颤导线单中心经验[J]. 中华心律失常学杂志, 2022, 26(6):511-515.
|
| [34] |
Kusumoto FM, Schoenfeld MH, Wilkoff BL, et al. 2017 HRS Expert consensus statement on cardiovascular implant‐able electronic device lead management and extraction[J].Heart Rhythm, 2017, 14(12):e503-e551.
|
| [35] |
Kellnar A, Fichtner S, Reitinger P, et al. Prevalence, man‐agement, and prediction of venous access site occlusion in patients undergoing lead revision surgery[J]. Int J Car‐diol, 2023, 381:16-19.
|
| [36] |
Mehta VS, Elliott MK, Sidhu BS, et al. Long-term survival following transvenous lead extraction: importance of indi‐cation and comorbidities[J]. Heart Rhythm, 2021, 18(9):1566-1576.
|
| [37] |
Lee JZ, Tan MC, Karikalan S, et al. Causes of Early Mortali‐ty after transvenous lead removal[J]. JACC Clin Electro‐physiol, 2022, 8(12):1566-1575.
|
| [38] |
Haeberlin A, Noti F, Breitenstein A, et al. Transvenous lead extraction during cardiac implantable device up-grade: re‐sults from the multicenter Swiss lead extraction registry[J]. J Clin Med, 2023, 12(16):5175.
|
| [39] |
Seo J, Kim DY, Cho I, et al. Prevalence, predictors, and prognosis of tricuspid regurgitation following permanent pacemaker implantation[J]. PLoS One, 2020, 15(6):e0235230.
|
| [40] |
Polewczyk A, Kutarski A, Tomaszewski A, et al. Lead de‐pendent tricuspid dysfunction: analysis of the mechanism and management in patients referred for transvenous lead extraction[J]. Cardiol J, 2013, 20(4):402-410.
|
| [41] |
Khan A, Zelin K, Karpawich PP. Performance of the lumen‐less 4.1-Fr diameter pacing lead implanted at alternative pacing sites in congenital heart: a chronic 5-year compari‐son[J]. Pacing Clin Electrophysiol, 2010, 33(12):1467-1474.
|
| [42] |
Yang YH, Wang KX, Ma PP, et al. His-purkinje system pac‐ing upgrade improve the heart performances in patients suffering from pacing-induced cardiomyopathy with or without permanent atrial fibrillation[J]. Int J Cardiol,2021, 335:47-51.
|
| [43] |
Koniari I, Gerakaris A, Kounis N, et al. Outcomes of Atrio‐ventricular node ablation and pacing in patients with heart failure and atrial fibrillation: from cardiac resyn‐chronization therapy to His bundle pacing[J]. J Cardiovasc Dev Dis, 2023, 10(7):272.
|
| [44] |
Abu-El-Haija B, Bhave PD, Campbell DN, et al. Venous ste‐nosis after transvenous lead placement: a study of out‐comes and risk factors in 212 consecutive patients[J]. J Am Heart Assoc, 2015, 4(8):e001878.
|
| [45] |
Vijayaraman P, Herweg B, Ellenbogen KA, et al. His-opti‐mized cardiac resynchronization therapy to maximize electrical resynchronization: a feasibility study[J]. Circ Ar‐rhythm Electrophysiol, 2019, 12(2):e006934.
|
| [46] |
Vijayaraman P, Pokharel P, Subzposh FA, et al. His-Purkin‐je Conduction system pacing optimized trial of cardiac re‐synchronization therapy vs biventricular pacing:HOT-CRT clinical trial[J]. JACC Clin Electrophysiol, 2023,9(12):2628-2638.
|